Plextek has collaborated with PneumaCare since its formation, contributing ideas, strategic consultancy and supporting the design of a working prototype to help prove the concept. Plextek has since worked on further technology development as PneumaCare commercialises the concept and looks at other potential applications. The collaboration has enabled PneumaCare to hit the key commercial milestones of Medical Regulatory approvals within the challenging schedule and budget requirements. Receiving the Medical Futures awards is a fantastic independent validation of the potential of PneumaCare’s business proposition.
PneumaScan is a revolutionary technology based on novel 3D imaging technology first developed by the University of Cambridge, UK. Clinical and commercial use of PneumaScan is about to start at Papworth and Addenbrooke’s Hospitals in Cambridge, Radcliffe Hospital in Oxford and Sheffield Children’s Hospital.
Plextek has a track record for delivering high quality, rapid and reliable healthcare design services (including industrial design, embedded software, analogue and digital hardware design, design for manufacture and rapid prototyping) to support companies with the development of electronic products for medical devices, diagnostics devices, telemedicine systems and biotechnology equipment. The company’s experience in medical device design and its knowledge of regulatory affairs means that all work is carried out to the highest quality and in full accordance with appropriate international standards.